Are antidepressants and psychotherapy equally effective in treating depression? A critical commentary

References

• Babyak M, Blumenthal JA, Herman S, et al. (2000). Exercise treatment for major depression: Maintenance of therapeutic benefit at 10 months. Psychosom Med, 62, 633–8
   PubMed Web of Science ®Google Scholar
• Barlow DH, Gorman JM, Shear MK, Woods SW. (2000). Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial. JAMA, 283, 2529–36
   PubMed Web of Science ®Google Scholar
• Casacalenda N, Perry JC, Looper K. (2002). Remission in major depressive disorder: A comparison of pharmacotherapy, psychotherapy, and control conditions. Am J Psychiatry, 159, 1354–60
   PubMed Web of Science ®Google Scholar
• Cuijpers P, Hollon SD, van Straten A, et al. (2013a). Does cognitive behaviour therapy have an enduring effect that is superior to keeping patients on continuation pharmacotherapy? A meta-analysis. BMJ Open, 3, e002542
   PubMed Web of Science ®Google Scholar
• Cuijpers P, Sijbrandij M, Koole SL, et al. (2013b). The efficacy of psychotherapy and pharmacotherapy in treating depressive and anxiety disorders: A meta-analysis of direct comparisons. World Psychiatry, 12, 137–48
   PubMed Web of Science ®Google Scholar
• Cuijpers P, Sijbrandij M, Koole SL, et al. (2014a). Adding psychotherapy to antidepressant medication in depression and anxiety disorders: A meta-analysis. World Psychiatry, 13, 56–67
   PubMed Web of Science ®Google Scholar
• Cuijpers P, Turner EH, Mohr DC, et al. (2014b). Comparison of psychotherapies for adult depression to pill placebo control groups: A meta-analysis. Psychol Med, 44, 685–95
   PubMed Web of Science ®Google Scholar
• Cuijpers P, van Straten A, van Oppen P, Andersson G. (2008). Are psychological and pharmacologic interventions equally effective in the treatment of adult depressive disorders? A meta-analysis of comparative studies. J Clin Psychiatry, 69, 1675–85
   PubMed Web of Science ®Google Scholar
• David D, Szentagotai A, Lupu V, Cosman D. (2008). Rational emotive behavior therapy, cognitive therapy, and medication in the treatment of major depressive disorder: A randomized clinical trial, posttreatment outcomes, and six-month follow-up. J Clin Psychol, 64, 728–46
   PubMed Web of Science ®Google Scholar
• DeRubeis RJ, Hollon SD, Amsterdam JD, et al. (2005). Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch Gen Psychiatry, 62, 409–16
   PubMed Web of Science ®Google Scholar
• Foa EB, Liebowitz MR, Kozak MJ, et al. (2005). Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. Am J Psychiatry, 162, 151–61
   PubMed Web of Science ®Google Scholar
• Huhn M, Tardy M, Spineli LM, et al. (2014). Efficacy of pharmacotherapy and psychotherapy for adult psychiatric disorders: A systematic overview of meta-analyses. JAMA Psychiatry, 71, 706–15
   PubMed Web of Science ®Google Scholar
• Imel ZE, Malterer MB, McKay KM, Wampold BE. (2008). A meta-analysis of psychotherapy and medication in unipolar depression and dysthymia. J Affect Disord, 110, 197–206
   PubMed Web of Science ®Google Scholar
• Iovieno N, Tedeschini E, Levkovitz Y, et al. (2012). Does the frequency of follow-up assessments affect clinical trial outcome? A meta-analysis and meta-regression of placebo-controlled randomized trials. Int J Neuropsychopharmacol, 15, 289–96
   PubMed Web of Science ®Google Scholar
• Khan A, Faucett J, Lichtenberg P, et al. (2012). A systematic review of comparative efficacy of treatments and controls for depression. PLoS One, 7, e41778
   PubMed Web of Science ®Google Scholar
• Khin NA, Kronstein PD, Yang P, et al. (2015). Regulatory and scientific issues in studies to evaluate sexual dysfunction in antidepressant drug trials. J Clin Psychiatry, 76, 1060–3
   PubMed Web of Science ®Google Scholar
• Kirsch I, Deacon BJ, Huedo-Medina TB, et al. (2008). Initial severity and antidepressant benefits: A meta-analysis of data submitted to the Food and Drug Administration. PLoS Med, 5, e45
   PubMed Web of Science ®Google Scholar
• Kirsch I, Sapirstein G. (1998). Listening to Prozac but hearing placebo: A meta-analysis of antidepressant medication. Prevent Treatment, 1, 2a
   Google Scholar
• Lambert MJ, Ogles BM. (2004). The efficacy and effectiveness of psychotherapy. In: Lambert MJ, ed. Bergin and Garfield's handbook of psychotherapy and behavior change. 5th ed. New York: Wiley, 139–93
   Google Scholar
• Mojtabai R, Olfson M. (2008). National patterns in antidepressant treatment by psychiatrists and general medical providers: Results from the national comorbidity survey replication. J Clin Psychiatry, 69, 1064–74
   PubMed Web of Science ®Google Scholar
• Morrato EH, Libby AM, Orton HD, et al. (2008). Frequency of provider contact after FDA advisory on risk of pediatric suicidality with SSRIs. Am J Psychiatry, 165, 42–50
   PubMed Web of Science ®Google Scholar
• Naudet F, Maria AS, Falissard B. (2011). Antidepressant response in major depressive disorder: A meta-regression comparison of randomized controlled trials and observational studies. PLoS One, 6, e20811
   PubMed Web of Science ®Google Scholar
• Posternak MA, Zimmerman M. (2007). Therapeutic effect of follow-up assessments on antidepressant and placebo response rates in antidepressant efficacy trials: Meta-analysis. Br J Psychiatry, 190, 287–92
   PubMed Web of Science ®Google Scholar
• Rutherford BR, Roose SP. (2013). A model of placebo response in antidepressant clinical trials. Am J Psychiatry, 170, 723–33
   PubMed Web of Science ®Google Scholar
• Rutherford BR, Sneed JR, Tandler JM, et al. (2011). Deconstructing pediatric depression trials: An analysis of the effects of expectancy and therapeutic contact. J Am Acad Child Adolesc Psychiatry, 50, 782–95
   PubMed Web of Science ®Google Scholar
• Serretti A, Chiesa A. (2009). Treatment-emergent sexual dysfunction related to antidepressants: A meta-analysis. J Clin Psychopharmacol, 29, 259–66
   PubMed Web of Science ®Google Scholar
• Severus E, Seemuller F, Berger M, et al. (2012). Mirroring everyday clinical practice in clinical trial design: A new concept to improve the external validity of randomized double-blind placebo-controlled trials in the pharmacological treatment of major depression. BMC Med, 10, 67
   PubMed Web of Science ®Google Scholar
• Sneed JR, Rutherford BR, Rindskopf D, et al. (2008). Design makes a difference: A meta-analysis of antidepressant response rates in placebo-controlled versus comparator trials in late-life depression. Am J Geriatr Psychiatry, 16, 65–73
   PubMed Web of Science ®Google Scholar
• Spielmans GI, Berman MI, Usitalo AN. (2011). Psychotherapy versus second-generation antidepressants in the treatment of depression: A meta-analysis. J Nerv Ment Dis, 199, 142–9
   PubMed Web of Science ®Google Scholar
• Stettin GD, Yao J, Verbrugge RR, Aubert RE. (2006). Frequency of follow-up care for adult and pediatric patients during initiation of antidepressant therapy. Am J Manag Care, 12, 453–61
   PubMed Web of Science ®Google Scholar
• Sugarman MA, Loree AM, Baltes BB, et al. (2014). The efficacy of paroxetine and placebo in treating anxiety and depression: A meta-analysis of change on the Hamilton Rating Scales. PLoS One, 9, e106337
   PubMed Web of Science ®Google Scholar
• Trivedi MH, Rush AJ, Wisniewski SR, et al. (2006). Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice. Am J Psychiatry, 163, 28–40
   PubMed Web of Science ®Google Scholar
• Turner EH, Matthews AM, Linardatos E, et al. (2008). Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med, 358, 252–60
   PubMed Web of Science ®Google Scholar
• Wennerstrom A, Hargrove L, Minor S, et al. (2015). Integrating community health workers into primary care to support behavioral health service delivery: A pilot study. J Ambul Care Manage, 38, 263–72
   PubMedGoogle Scholar
• Zimmerman M, Galione JN, Attiullah N, et al. (2010). Underrecognition of clinically significant side effects in depressed outpatients. J Clin Psychiatry, 71, 484–90
   PubMed Web of Science ®Google Scholar